View more on these topics

Zurich enhances critical illness product

Zurich has revamped its critical illness product, adding eight new conditions, including six new partial payment conditions.


The two new conditions covered are benign spinal cord tumour and pneumonectomy.

The new partial payment conditions, where 20 per cent of the sum assured or £15,000 is paid to the customer, whichever is lower, are: Carcinoma in situ of the breast requiring mastectomy or lumpectomy; low-grade prostate cancer; carcinoma in situ of the testicle; carcinoma in situ of the urinary bladder; non-malignant pituitary adenoma; and cerebral aneurysm, treated by craniotomy or endovascular repair.

Zurich now pays out where the patient opts for both a lumpectomy or mastectomy, so the person can choose their preferred treatment method without it affecting the paying out.

Now the insurer covers 48 conditions, including 10 at Association of British Insurers +, meaning the definition goes beyond the trade body’s standard definition.

Zurich head of retail propositions Peter Hamilton says: “We feel that the changes we have introduced provide the right level of cover, adding real value, and we hope reassurance to our customers.”

Highclere Financial Services partner Alan Lakey says: “These improvements, allied to Zurich’s keen pricing, positions them as a value-for-money choice for discriminating advisers.”


MS Leader: An inconclusive ruling

Over the last year, Mortgage Strategy has reported on claims management companies salivating over the mortgage sector, in particular interest-only. So far, claims firms have had to be content to just talk up the sector and there has been little evidence that we would see the same avalanche of claims as has been seen in […]


News and expert analysis straight to your inbox

Sign up